Literature DB >> 28055145

Conformational quiescence of ADAMTS-13 prevents proteolytic promiscuity: comment.

W J Cao1, X L Zheng1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28055145      PMCID： PMC5334213          DOI： 10.1111/jth.13610

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  10 in total

1.  Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.

Authors:  Cui Jian; Juan Xiao; Lingjie Gong; Christopher G Skipwith; Sheng-Yu Jin; Hau C Kwaan; X Long Zheng
Journal:  Blood       Date:  2012-01-30       Impact factor: 22.113

2.  Cleavage of von Willebrand factor requires the spacer domain of the metalloprotease ADAMTS13.

Authors:  Xinglong Zheng; Kenji Nishio; Elaine M Majerus; J Evan Sadler
Journal:  J Biol Chem       Date:  2003-06-05       Impact factor: 5.157

3.  Allosteric activation of ADAMTS13 by von Willebrand factor.

Authors:  Joshua Muia; Jian Zhu; Garima Gupta; Sandra L Haberichter; Kenneth D Friedman; Hendrik B Feys; Louis Deforche; Karen Vanhoorelbeke; Lisa A Westfield; Robyn Roth; Niraj Harish Tolia; John E Heuser; J Evan Sadler
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

Review 4.  ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura.

Authors:  X Long Zheng
Journal:  Annu Rev Med       Date:  2015       Impact factor: 13.739

5.  Carboxyl terminus of ADAMTS13 directly inhibits platelet aggregation and ultra large von Willebrand factor string formation under flow in a free-thiol-dependent manner.

Authors:  Jialing Bao; Juan Xiao; Yingying Mao; X Long Zheng
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-12-19       Impact factor: 8.311

6.  Exosite interactions contribute to tension-induced cleavage of von Willebrand factor by the antithrombotic ADAMTS13 metalloprotease.

Authors:  Weiqiang Gao; Patricia J Anderson; Elaine M Majerus; Elodee A Tuley; J Evan Sadler
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-04       Impact factor: 11.205

7.  ADAMTS13 exerts a thrombolytic effect in microcirculation.

Authors:  Marilena Crescente; Grace M Thomas; Melanie Demers; Jaymie R Voorhees; Siu Ling Wong; Benoit Ho-Tin-Noé; Denisa D Wagner
Journal:  Thromb Haemost       Date:  2012-07-10       Impact factor: 5.249

8.  Conformational activation of ADAMTS13.

Authors:  Kieron South; Brenda M Luken; James T B Crawley; Rebecca Phillips; Mari Thomas; Richard F Collins; Louis Deforche; Karen Vanhoorelbeke; David A Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

9.  A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF.

Authors:  Sara Zanardelli; Alain C K Chion; Evelyn Groot; Peter J Lenting; Thomas A J McKinnon; Mike A Laffan; Michelle Tseng; David A Lane
Journal:  Blood       Date:  2009-07-08       Impact factor: 22.113

10.  Conformational quiescence of ADAMTS-13 prevents proteolytic promiscuity.

Authors:  K South; M O Freitas; D A Lane
Journal:  J Thromb Haemost       Date:  2016-09-23       Impact factor: 5.824
  10 in total
  2 in total

1.  Phylogenetic and functional analysis of ADAMTS13 identifies highly conserved domains essential for allosteric regulation.

Authors:  Joshua Muia; Jian Zhu; Suellen C Greco; Karen Vanhoorelbeke; Garima Gupta; Lisa A Westfield; J Evan Sadler
Journal:  Blood       Date:  2019-01-30       Impact factor: 22.113

Review 2.  ADAMTS-13 and von Willebrand factor: a dynamic duo.

Authors:  K South; D A Lane
Journal:  J Thromb Haemost       Date:  2017-12-02       Impact factor: 5.824
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.